1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"NINDS Small Business Program Areas of Interest" is currently closed and not accepting applications.
NINDS Small Business Program Areas of Interest is sponsored by National Institute of Neurological Disorders and Stroke (NINDS) / NIH. The NINDS SBIR/STTR program funds small business concerns to conduct innovative neuroscience research and/or development that has both the potential for commercialization and public benefit.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NINDS Small Business Program | National Institute of Neurological Disorders and Stroke NINDS Small Business Program The National Institutes of Health ( NIH ) Small Business Program is a congressionally-mandated set-aside program to encourage research and development leading to commercialization.
The NINDS Small Business Program is used to achieve the mission of the Institute by supporting innovative ideas at different stages of development, including applied bench research, translational research, and early-stage clinical trials. Potential applicants should send a brief abstract or overview of their technology at least one month before the SBIR/STTR standard deadline . Contact Small Business Program staff at: NINDS_SBIR@ninds.
nih. gov Further questions? Visit our list of NINDS Small Business FAQS .
Learn more about the NINDS Small Business Program Compare our programs and grants View our areas of interest and NIH-wide initiatives How to prepare and submit an application NINDS SBIR/STTR funding decision process Awardees seeking collaboration or investment Resources for commercialization Applicant FAQs and resources Frequently Asked Questions Portfolio Companies selected for investor events Last reviewed on July 10, 2026
According to the current listing, eligibility includes: U. S. -based, for-profit small business with 500 or fewer employees, at least 51% owned by U. S. citizens or permanent residents. Principal Investigator (PI) must be primarily employed by the small business. Confirm the full requirements in the official notice before applying.
The current listing shows not specified (SBIR/STTR typically up to $250,000 for Phase I and $1.6 million for Phase II). Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was September 5, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
NINDS Small Business Program Areas of Interest is funded by National Institute of Neurological Disorders and Stroke (NINDS) / NIH. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VCID) in the United States (U19 - Clinical Trial Not Allowed) is sponsored by National Institute of Neurological Disorders and Stroke (NINDS) / NIH. This is a non-competitive funding opportunity intended to fund a single award to support the renewal of the Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VCID) in the United States.
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) is sponsored by National Institute of Neurological Disorders and Stroke (NINDS) / NIH. Part of the HEAL (Helping to End Addiction Long-term) Initiative, this opportunity focuses on the development of non-addictive analgesic therapeutics, including small molecules and biologics, to treat pain.
PAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read articleThe HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read article